Discontinuation report GARDASIL

Last updated on 2019-08-23 History
Report ID 92342
Drug Identification Number 02283190
Brand name GARDASIL
Common or Proper name Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] - Suspension for Injection
Company Name MERCK CANADA INC
Active Ingredient(s) RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Strength(s) 20MCG 40MCG 40MCG 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1 Dose
ATC code J07BM
ATC description VIRAL VACCINES
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-08-22
Remaining supply date 2018-12-04
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-08-23 French Compare
v1 2019-08-23 English Compare